The mechanism underlying the resistance of cancer cells to chemotherapy is complicated and involves the activation of PI3K/Akt (also known as PI3K/PKB) pathway, the loss of p53 function, over-expression of HER-2/neu and anti-apoptotic bcl-2, and the compromised caspase activation [2], [3]. Here, ERBB2 is linked to cancer.